StatBite: Global Survey: Women Living With Metastatic Breast Cancer and Clinical Trial Participation

Metastatic Breast ◽

Trial Participation ◽

Global Survey

A virtual consult service to optimize clinical trial participation in patients with metastatic breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.6601 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 6601-6601

Author(s):

Karen Anne Cadoo ◽

Payal Deepak Shah ◽

Alexandra Snyder Charen ◽

Jacqueline Bromberg ◽

Elizabeth Anne Comen ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast ◽

Trial Participation ◽

Consult Service

Abstract 2624: Clinical trial participation in real-world patients with metastatic breast cancer: disparities and barriers

10.1158/1538-7445.am2021-2624 ◽

2021 ◽

Author(s):

Ruoding Tan ◽

Rongrong Wang ◽

Ibrahim Abbass ◽

Lourenia Cassoli ◽

Edith P. Mitchell

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Real World ◽

Metastatic Breast ◽

Cancer Disparities ◽

Trial Participation ◽

Breast Cancer Disparities

116 A phase I clinical trial to evaluate the pharmacokinetics, toxicity and dosimetry of 111-indium-labeled human epidermal growth factor in patients with metastatic breast cancer

Radiotherapy and Oncology ◽

10.1016/s0167-8140(05)80277-4 ◽

2005 ◽

Vol 76 ◽

pp. S35

Author(s):

K. Vallis ◽

R. Reilley ◽

D. Scollard ◽

J. Petronis ◽

C. Caldwell ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial ◽

Human Epidermal Growth Factor ◽

Epidermal Growth

A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer

Cancer Medicine ◽

10.1002/cam4.447 ◽

2015 ◽

Vol 4 (7) ◽

pp. 1051-1059 ◽

Cited By ~ 21

Author(s):

Pavani Chalasani ◽

Marilyn Marron ◽

Denise Roe ◽

Kathryn Clarke ◽

Maria Iannone ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Phase I ◽

Metastatic Breast ◽

Phase I Clinical Trial

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-018-05070-2 ◽

2018 ◽

Vol 174 (2) ◽

pp. 433-442 ◽

Cited By ~ 17

Author(s):

O. Nanni ◽

◽

D. Amadori ◽

A. De Censi ◽

A. Rocca ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Metastatic Breast ◽

Line Treatment ◽

Phase 2 ◽

First Line ◽

Phase 2 Clinical Trial ◽

Randomized Phase 2 ◽

First Line Treatment

Life Skills Training Effectiveness on Non-Metastatic Breast Cancer Mental Health: A Clinical Trial

Iranian Red Crescent Medical Journal ◽

10.5812/ircmj.8763 ◽

2014 ◽

Vol 16 (1) ◽

Cited By ~ 6

Author(s):

Mina Shabani ◽

Minoosh Moghimi ◽

Reza Eghdam Zamiri ◽

Fatemeh Nazari ◽

Nouraddin Mousavinasab ◽

...

Keyword(s):

Breast Cancer ◽

Mental Health ◽

Clinical Trial ◽

Life Skills ◽

Metastatic Breast ◽

Skills Training ◽

Training Effectiveness ◽

Life Skills Training

Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation - a qualitative study

Sociology of Health & Illness ◽

10.1111/1467-9566.12307 ◽

2015 ◽

Vol 37 (8) ◽

pp. 1373-1387 ◽

Cited By ~ 3

Author(s):

Christine Holmberg ◽

Katie Whitehouse ◽

Mary Daly ◽

Worta McCaskill-Stevens

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Breast Cancer Risk ◽

Qualitative Study ◽

Cancer Risk ◽

Trial Participation ◽

The Future

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

Breast Cancer Research and Treatment ◽

10.1007/s10549-012-2045-1 ◽

2012 ◽

Vol 134 (1) ◽

pp. 283-289 ◽

Cited By ~ 70

Author(s):

Marta Pestrin ◽

Silvia Bessi ◽

Fabio Puglisi ◽

Alessandro M. Minisini ◽

Giovanna Masci ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Single Agent ◽

Metastatic Breast ◽

Proof Of Concept ◽

Her2 Positive ◽

Multicenter Phase

Abstract PS13-01: Primary analysis of OVERSTEP: A multicenter, randomized clinical trial of capecitabine or endocrine therapy as a maintenance therapy after the 1st-line chemotherapy in hormone receptor positive and HER2-negative advanced/metastatic breast cancer

10.1158/1538-7445.sabcs20-ps13-01 ◽

2021 ◽

Author(s):

Jian Huang ◽

Xiying Shao ◽

Li Cai ◽

Yanxia Shi ◽

Zhanhong Chen ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Maintenance Therapy ◽

Randomized Clinical Trial ◽

Hormone Receptor ◽

Metastatic Breast ◽

Primary Analysis ◽

Hormone Receptor Positive ◽

Line Chemotherapy

Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆

Annals of Oncology ◽

10.1016/j.annonc.2020.06.020 ◽

2020 ◽

Vol 31 (10) ◽

pp. 1350-1358 ◽

Cited By ~ 9

Author(s):

F. Montemurro ◽

S. Delaloge ◽

C.H. Barrios ◽

R. Wuerstlein ◽

A. Anton ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Trial ◽

Brain Metastases ◽

Metastatic Breast ◽

Final Analysis ◽

Trastuzumab Emtansine ◽

Her2 Positive ◽

Phase Iiib